Ropes & Gray represented ImmunoGen, Inc. on the deal. ImmunoGen, Inc., a leader in the field of antibody-drug conjugates, announced a global, multi-target license and option agreement...
ImmunoGen’s Global Multi-Target License and Option Agreement with Vertex
Ironwood Pharmaceuticals’ Rare Autoimmune Disease Collaboration with COUR Pharmaceuticals
Ropes & Gray represented Ironwood Pharmaceuticals in the collaboration and license option agreement with COUR Pharmaceutical Development Company. The agreement gives Ironwood an option to acquire...